These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36716084)

  • 41. [Treatment results of Hodgkin's lymphoma].
    Aleknavicius E; Valuckas KP; Aleknaviciene B; Norkiene L; Smailyte G
    Medicina (Kaunas); 2009; 45(8):615-23. PubMed ID: 19773620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A
    J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hodgkin disease in children: reduced tailored chemotherapy for stage I-II disease.
    Yaniv I; Saab A; Cohen IJ; Goshen Y; Loven D; Stark B; Tamary H; Zaizov R
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):76-80. PubMed ID: 8556376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).
    Gorde-Grosjean S; Oberlin O; Leblanc T; Pacquement H; Donadieu J; Lambilliotte A; Schell M; Dommange F; Munzer M; Paillard C; Schmitt C; Lutz P; Edan C; Ansoborlo S; Stephan JL; Michel G; Thomas C; Perel Y; Robert A; Landman-Parker J
    Br J Haematol; 2012 Sep; 158(5):649-56. PubMed ID: 22757721
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
    Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group.
    Eichenauer DA; Plütschow A; Fuchs M; Sasse S; Baues C; Böll B; von Tresckow B; Diehl V; Borchmann P; Engert A
    J Clin Oncol; 2020 Mar; 38(7):698-705. PubMed ID: 31626571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
    Mehreen A; Wali RM; Sindhu II; Asad M; Ria S
    J Pak Med Assoc; 2019 Sep; 69(9):1266-1272. PubMed ID: 31511710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.
    Akhtar S; Rauf SM; Elhassan TA; Maghfoor I
    Ann Hematol; 2016 Sep; 95(9):1521-35. PubMed ID: 27376363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
    Englund A; Hopstadius C; Enblad G; Gustafsson G; Ljungman G
    Acta Oncol; 2015 Jan; 54(1):41-8. PubMed ID: 25203597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
    Kelly KM; Sposto R; Hutchinson R; Massey V; McCarten K; Perkins S; Lones M; Villaluna D; Weiner M
    Blood; 2011 Mar; 117(9):2596-603. PubMed ID: 21079154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
    Josting A; Rudolph C; Mapara M; Glossmann JP; Sieniawski M; Sieber M; Kirchner HH; Dörken B; Hossfeld DK; Kisro J; Metzner B; Berdel WE; Diehl V; Engert A
    Ann Oncol; 2005 Jan; 16(1):116-23. PubMed ID: 15598948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma.
    Pinczés L; Miltényi Z; Illés Á
    J Cancer Res Clin Oncol; 2018 May; 144(5):935-943. PubMed ID: 29468437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Can children with Hodgkin's disease be treated with chemotherapy only?].
    Balwierz W; Klekawka T; Moryl-Bujakowska A; Matysiak M; Sopyło B; Wachowiak J; Kaczmarek-Kanold M; Sońta-Jakimczyk D; Janik-Moszant A; Chybicka A; Chaber R; Kowalczyk JR; Mitura-Lesiuk M; Balcerska A; Stachowicz-Stencel T; Wysocki M; Kołtan A; Krawczuk-Rybak M; Muszyńska-Rosłan K; Młynarski W; Stolarska M; Sobol G; Wieczorek M; Karolczyk G; Urbanek-Dadela A
    Przegl Lek; 2010; 67(6):375-81. PubMed ID: 21344765
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Our experiences in treating patients with Hodgkin disease in the last decade].
    Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A
    Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Should children with non-Hodgkin lymphoma be treated with different protocols according to histopathologic subtype?
    Lee SH; Yoo KH; Sung KW; Ko YH; Lee JW; Koo HH
    Pediatr Blood Cancer; 2013 Nov; 60(11):1842-7. PubMed ID: 23857875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
    Nachman JB; Sposto R; Herzog P; Gilchrist GS; Wolden SL; Thomson J; Kadin ME; Pattengale P; Davis PC; Hutchinson RJ; White K;
    J Clin Oncol; 2002 Sep; 20(18):3765-71. PubMed ID: 12228196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.